Focusing on 'breakthroughs & controversies in mood, psychosis, schizophrenia, ADHD, and insomnia', the CINP 2019 Athens Meeting will highlight cutting edge pre-clinical, clinical or translational research, presented by recognized speakers and leaders in the field. Through the free and open exchange of ideas, CINP supports a strong focus on new approaches to the development and assessment of CNS pharmaceuticals by researchers working in both academia and industry. In addition to Keynote Lectures and Educational Symposia, the Meet the Expert Sessions, Workshops and the Young Investigator Forum will provide an excellent platform for audience participation and will be highly interactive.
Late-breaking abstract submission deadline
5 August 2019
Regular registration deadline
21 August 2019
3 - 5 October 2019
CINP 2019 Confirmed Speakers
The CINP International Scientific Programme Committee is pleased to announce a panel of remarkable speakers recognized internationally for their exceptional achievements and research in a wide range of disciplines within the field.